Cite
HARVARD Citation
Zhao, J. et al. (2017). (−)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of α-synuclein, and protects PC12 cells against α-synuclein-induced toxicity. RSC advances. 7 (52), pp. 32508-32517. [Online].